Healthcare Global Enterprises Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹732 Cr +13.1% YoYSee revenue, profit and what management said. You are viewing Q4 FY25.
HG

Healthcare Global Enterprises Ltd

Q4 FY25Healthcare Services

Healthcare Global Enterprises Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management said on revenue, margins and capex.

Revenue
₹585Cr
+18.3% YoY
+4.8% QoQ
Net profit
₹7Cr
−71.1% YoY
−12.6% QoQ
Margin
18.05%
−0.6 pp YoY
+2.2 pp QoQ

Healthcare Global Enterprises Ltd Q4 FY25 key numbers

Revenue
FY '25 revenue grew 16% to INR 2,223 crores; Q4 revenue rose 18% YoY to INR 585 crores.

As stated in Healthcare Global Enterprises Ltd's Q4 FY25 earnings call transcript · published 8 Aug 2026. Reported figures, not investment advice.

Price₹726
Market cap₹10.7K Cr
P/E221.4

The short version

FY '25 revenue grew 16% to INR 2,223 crores; Q4 revenue rose 18% YoY to INR 585 crores. HCG expects continued strong revenue and EBITDA growth in FY '26, building on a 16-18% revenue growth in FY '25 and a 44% EBITDA increase in emerging centers.

From Healthcare Global Enterprises Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • FY '25 revenue grew 16% to INR 2,223 crores; Q4 revenue rose 18% YoY to INR 585 crores.
  • Excluding Milann, core HCG centers saw 17% revenue growth and 17% EBITDA growth in FY '25.
  • Outpatient footfall increased by 13.8%; chemotherapy sessions grew 24%, indicating higher patient demand.
  • Emerging centers delivered 32% revenue growth with improving EBITDA margins, expected to boost overall margins.
  • Digital revenue doubled in FY '25; with efforts to scale digital channels further expected to contribute significantly to top-line growth.
  • New facilities: flagship 189-bed center in Ahmedabad operationalized; two new hospitals in Bangalore to come online in FY '26 to tap new markets and enhance capacity.
  • Plans to operationalize over 900 beds across the network within 3 years including 350 beds invested but not yet operational.

2 more points from Healthcare Global Enterprises Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Healthcare Global Enterprises Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY '26 Capex planned at approximately INR 286 crores focused on network expansion and technology upgrades, including existing centers in Bangalore and Cuttack.
  • Addition of over 900 beds across the network within the next 3 years, including 350 beds fully invested but not yet operational.
  • Investment in advanced technologies such as linear accelerator (LINAC) machines, PET-CT scanners, and robotic surgery platforms to enhance precision cancer care.
  • Two new hospitals to commence operations in Bangalore in FY '26: one in North Bangalore (second half of FY '26) and another in Whitefield as an extension of the flagship center.

2 more points from Healthcare Global Enterprises Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Healthcare Global Enterprises Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Healthcare Global Enterprises Ltd said on order book & pipeline — free account, 30 seconds.

Healthcare Global Enterprises Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Healthcare Global Enterprises Ltd Q4 FY25 results — key figures

Healthcare Global Enterprises Ltd Q4 FY25 reported results vs Q4 FY24, ₹ crore
₹ CrQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue585495+18.3%559+4.8%
Operating profit (EBITDA)10692+14.8%88+19.5%
Operating margin18.05%18.61%-0.6 pp15.82%+2.2 pp
Profit before tax1428-51.7%-3—
Net profit (PAT)723-71.1%8-12.6%
EPS (₹)0.521.52-65.8%0.50+4%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹732 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • 3B Blackbio (Q4 FY25)

    UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…

  • Apollo Hospitals (Q4 FY25)

    . Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Shalby (Q4 FY25)

    Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…

  • Narayana Hrudaya (Q4 FY25)

    Capex is split between regular maintenance/replacement (~INR 300 crores) and new greenfield/brownfield capacity (~INR 450 crores) with some variability based…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Healthcare Global Enterprises Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Healthcare Global Enterprises Ltd Q4 FY25 results?

FY '25 revenue grew 16% to INR 2,223 crores; Q4 revenue rose 18% YoY to INR 585 crores. HCG expects continued strong revenue and EBITDA growth in FY '26, building on a 16-18% revenue growth in FY '25 and a 44% EBITDA increase in emerging centers.

What is Healthcare Global Enterprises Ltd share price analysis?

Healthcare Global Enterprises Ltd currently shows a neutral. The stock trades at a P/E of 221.3 with a market cap of ₹10,665 Cr. Investors should review the full earnings analysis for detailed insights.

Is Healthcare Global Enterprises Ltd planning capital expenditure?

FY '26 Capex planned at approximately INR 286 crores focused on network expansion and technology upgrades, including existing centers in Bangalore and Cuttack.

Keep Healthcare Global Enterprises Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.